Bravias Capital Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Bravias Capital Group's PFE Position: Q3 2026 in Review
Bravias Capital Group opened a new position in Pfizer (PFE) in Q3 2026: 7,938 shares worth $226K. The stake represents 0.13% of the portfolio and ranks #95 among its holdings. This is a return to the name: Bravias Capital Group previously reported a position in PFE as recently as Q1 2026.
Bravias Capital Group first reported a position in PFE in Q1 2026 and has held it in 2 quarters since. 2,904 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Bravias Capital Group held 7,938 shares of Pfizer worth $226K as of Q3 2026.
- Pfizer was a new Bravias Capital Group position in Q3 2026.
- Pfizer made up 0.13% of Bravias Capital Group's portfolio in Q3 2026, its #95 holding.
- Bravias Capital Group first reported a position in Pfizer in Q1 2026 and has held it in 2 quarters since.
- 2,904 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Bravias Capital Group's 13F filing for Q3 2026, filed 12 Nov 2026.